C WorldWide Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.8M | Buy |
261,110
+100,000
| +62% | +$12.1M | 0.67% | 25 |
|
|
2026
Q1 | $26.3M | Buy |
161,110
+25,000
| +18% | +$3.84M | 0.57% | 26 |
|
|
2025
Q4 | $23.7M | Sell |
136,110
-60,000
| -31% | -$10.9M | 0.41% | 33 |
|
|
2025
Q3 | $28.2M | Sell |
196,110
-75,000
| -28% | -$9.19M | 0.44% | 28 |
|
|
2025
Q2 | $27.3M | Sell |
271,110
-50,000
| -16% | -$3.82M | 0.37% | 30 |
|
|
2025
Q1 | $24.5M | Sell |
321,110
-22,000
| -6% | -$1.68M | 0.3% | 31 |
|
|
2024
Q4 | $23.7M | Hold |
343,110
| – | – | 0.29% | 32 |
|
|
2024
Q3 | $25M | Hold |
343,110
| – | – | 0.26% | 48 |
|
|
2024
Q2 | $23M | Hold |
343,110
| – | – | 0.25% | 50 |
|
|
2024
Q1 | $9.31M | Hold |
343,110
| – | – | 0.11% | 63 |
|
|
2023
Q4 | $10.6M | Hold |
343,110
| – | – | 0.14% | 59 |
|
|
2023
Q3 | $8.66M | Hold |
343,110
| – | – | 0.12% | 58 |
|
|
2023
Q2 | $7.24M | Hold |
343,110
| – | – | 0.09% | 65 |
|
|
2023
Q1 | $5.85M | Hold |
343,110
| – | – | 0.08% | 65 |
|
|
2022
Q4 | $6.86M | Hold |
343,110
| – | – | 0.09% | 51 |
|
|
2022
Q3 | $7.39M | Hold |
343,110
| – | – | 0.1% | 49 |
|
|
2022
Q2 | $6.77M | Hold |
343,110
| – | – | 0.08% | 51 |
|
|
2022
Q1 | $8.06M | Hold |
343,110
| – | – | 0.09% | 50 |
|
|
2021
Q4 | $9.35M | Hold |
343,110
| – | – | 0.09% | 51 |
|
|
2021
Q3 | $9.45M | Hold |
343,110
| – | – | 0.1% | 49 |
|
|
2021
Q2 | $9.77M | Hold |
343,110
| – | – | 0.1% | 47 |
|
|
2021
Q1 | $11.7M | Sell |
343,110
-40,000
| -10% | -$1.53M | 0.11% | 53 |
|
|
2020
Q4 | $12.8M | Sell |
383,110
-60,000
| -14% | -$2.19M | 0.13% | 51 |
|
|
2020
Q3 | $14.2M | Hold |
443,110
| – | – | 0.16% | 46 |
|
|
2020
Q2 | $12.2M | Hold |
443,110
| – | – | 0.14% | 47 |
|
|
2020
Q1 | $7.1M | Hold |
443,110
| – | – | 0.1% | 49 |
|
|
2019
Q4 | $10.6M | Hold |
443,110
| – | – | 0.13% | 48 |
|
|
2019
Q3 | $7.82M | Buy |
443,110
+50,000
| +13% | +$966K | 0.1% | 52 |
|
|
2019
Q2 | $10.1M | Buy |
393,110
+280,000
| +248% | +$7.8M | 0.13% | 52 |
|
|
2019
Q1 | $3.29M | Hold |
113,110
| – | – | 0.04% | 74 |
|
|
2018
Q4 | $1.48M | Sell |
113,110
-127,532
| -53% | -$2.03M | 0.02% | 90 |
|
|
2018
Q3 | $4.87M | Sell |
240,642
-170,312
| -41% | -$3.85M | 0.06% | 67 |
|
|
2018
Q2 | $9.72M | Buy |
410,954
+38,292
| +10% | +$986K | 0.13% | 41 |
|
|
2018
Q1 | $8.39M | Sell |
372,662
-19,345
| -5% | -$509K | 0.13% | 44 |
|
|
2017
Q4 | $12.2M | Sell |
392,007
-55,422
| -12% | -$1.64M | 0.18% | 37 |
|
|
2017
Q3 | $14M | Buy |
447,429
+305,958
| +216% | +$5.83M | 0.2% | 36 |
|
|
2017
Q2 | $2.43M | Buy |
141,471
+19,021
| +16% | +$325K | 0.04% | 91 |
|
|
2017
Q1 | $2.14M | Buy |
+122,450
| New | +$1.89M | 0.04% | 86 |
|
Other funds holding INSM
BBA
DGM
OAG
C WorldWide Group's INSM Position: Q2 2026 in Review
C WorldWide Group increased its Insmed (INSM) stake by 62% in Q2 2026, buying an estimated $12.1M and bringing the position to 261,110 shares worth $27.8M. The position accounts for 0.67% of the portfolio, ranked #25.
C WorldWide Group first reported a position in INSM in Q1 2017 and has held it in 38 quarters since. The position peaked at $28.2M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- C WorldWide Group held 261,110 shares of Insmed worth $27.8M as of Q2 2026.
- C WorldWide Group bought 100,000 Insmed shares in Q2 2026, an estimated $12.1M.
- Insmed made up 0.67% of C WorldWide Group's portfolio in Q2 2026, its #25 holding.
- C WorldWide Group first reported a position in Insmed in Q1 2017 and has held it in 38 quarters since.
- C WorldWide Group's Insmed position peaked at $28.2M in Q3 2025.
- 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.